News

Three Special Research Programme grants for Vienna BioCenter scientists

The highly collaborative environment of the Vienna BioCenter is once again demonstrated by three new Special Research Programmes (SFBs) going to…

Read more
Interdisciplinary panel discussion. ©Paul Pipernig

A large-scale public event bridging science and society

On December 2nd, a large-scale public event, organized by the City of Vienna in cooperation with the Vienna BioCenter took place in the Globe Theater.…

Read more

Putting a Lid on Multidrug Resistance

Multidrug resistance (MDR) is a fundamentally important medical phenomenon that undermines anticancer and anti-infective therapy of cancer or…

Read more

Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months

Valneva announced that the European Medicines Agency (EMA) has approved the extension of the shelf life of its Japanese encephalitis vaccine IXIARO® f…

Read more
CRISPR-Switch. ©IMBA/Kaminski Grafik

Harnessing the power of CRISPR in space and time

Researchers in Vienna from Ulrich Elling’s laboratory at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – in…

Read more
Innovation voucher

“Innovation Voucher” for Haplogen and the Metabolomics unit of the VBCF

Successful collaboration of research and industrial members of Vienna BioCenter awarded by the Austrian Research Promotion Agency (FFG) in the form of…

Read more

Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize

The prize was awarded for Ares Genetics’ ARESupa –Universal Pathogenome Assay, a diagnostic toolfor personalized antibiotic resistance diagnostics…

Read more

IMP researchers show that cohesin is a "molecular machine"

New insights into the process of DNA-looping change our view of how the genome is organised within cells. The discoveries by IMP-researchers now…

Read more

Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans

Valneva announced excellent final Phase 1 results for its single-shot chikungunya vaccine candidate, VLA1553.

 

Read more

Read more

Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board

Valneva announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Norman W. Baylor, PhD, and Dr. George R.…

Read more

Euro-BioImaging officially established with Austria as one of the founding members

The European Commission has officially established Euro-BioImaging – which provides life scientists with open access to a broad range of technologies…

Read more

Vienna BioCenter PhD Awards 2019

In the frame of the Vienna BioCenter PhD Student Symposium "Re-Connect", five former students of the international PhD Programme received awards for…

Read more